FAM198A, short for Family with Sequence Similarity 198 Member A, is a protein that has not been extensively characterized in terms of its biological function. The term "FAM" indicates that it belongs to a particular family of proteins that share sequence similarity, suggesting potential shared structural features or functional roles.The human FAM198A gene is located on chromosome 17, and the protein it encodes is expressed in multiple tissues, which implies a role in fundamental cellular processes. The exact role of FAM198A in these tissues, however, remains to be fully elucidated.
Bioinformatics analyses often predict potential functions for proteins like FAM198A based on their sequence similarity to other proteins with known functions, domain architecture, and expression patterns. For instance, if FAM198A contains domains that are typical of enzymes, it might be involved in catalytic processes within the cell. Alternatively, if it contains domains known for protein-protein interactions, it could play a role in signaling pathways or the assembly of protein complexes.The study of FAM198A could involve various experimental approaches, such as gene knockdown or knockout models to determine its role in cell biology and physiology. Additionally, protein interaction assays could be used to identify binding partners and place FAM198A within specific cellular pathways.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Rapamycin | 53123-88-9 | sc-3504 sc-3504A sc-3504B | 1 mg 5 mg 25 mg | $62.00 $155.00 $320.00 | 233 | |
Rapamycin inhibits mTOR, a key regulator of protein synthesis, potentially affecting FAM198A-related processes. | ||||||
Everolimus | 159351-69-6 | sc-218452 sc-218452A | 5 mg 50 mg | $128.00 $638.00 | 7 | |
Everolimus, an mTOR inhibitor, may indirectly influence FAM198A function by altering protein synthesis regulation. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $121.00 $392.00 | 148 | |
LY294002, a PI3K inhibitor, could indirectly affect FAM198A by modulating the PI3K/AKT/mTOR pathway. | ||||||
Wortmannin | 19545-26-7 | sc-3505 sc-3505A sc-3505B | 1 mg 5 mg 20 mg | $66.00 $219.00 $417.00 | 97 | |
Wortmannin, a potent PI3K inhibitor, may have an indirect impact on FAM198A through the PI3K/AKT pathway. | ||||||
PD 98059 | 167869-21-8 | sc-3532 sc-3532A | 1 mg 5 mg | $39.00 $90.00 | 212 | |
PD98059, an inhibitor of MEK, which is upstream of ERK, might affect FAM198A-related signaling indirectly. | ||||||
SP600125 | 129-56-6 | sc-200635 sc-200635A | 10 mg 50 mg | $40.00 $150.00 | 257 | |
SP600125, a JNK inhibitor, might have indirect effects on FAM198A through stress and cytokine signaling pathways. | ||||||
SB 203580 | 152121-47-6 | sc-3533 sc-3533A | 1 mg 5 mg | $88.00 $342.00 | 284 | |
SB203580, a p38 MAPK inhibitor, could indirectly influence FAM198A activity through MAPK pathway regulation. | ||||||
Sorafenib | 284461-73-0 | sc-220125 sc-220125A sc-220125B | 5 mg 50 mg 500 mg | $56.00 $260.00 $416.00 | 129 | |
Sorafenib, a multi-kinase inhibitor, might indirectly affect FAM198A by targeting various signaling pathways. | ||||||
Sunitinib, Free Base | 557795-19-4 | sc-396319 sc-396319A | 500 mg 5 g | $150.00 $920.00 | 5 | |
Sunitinib, with its broad tyrosine kinase inhibition, could potentially impact FAM198A-associated pathways. | ||||||
Dasatinib | 302962-49-8 | sc-358114 sc-358114A | 25 mg 1 g | $47.00 $145.00 | 51 | |
Dasatinib, primarily a BCR-ABL inhibitor, may have broader effects potentially impacting FAM198A's role. | ||||||